McKune John's Form 4 filing
Pulmonx Corp (LUNG) · filed Dec 5, 2023
- Accession no.
- 0001209191-23-057510
- Filed
- Dec 5, 2023
- Trade date
- Dec 1, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $9.74K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McKune JohnCIK 0001650427 | Officer (Interim CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | Common Stock | SSaleDisposed | −135 | $10.33 | −$1,394.55 | 41,221 | Direct | |
| Dec 1, 2023 | Common Stock | SSaleDisposed | −222 | $10.34 | −$2,295.48 | 40,999 | Direct | |
| Dec 1, 2023 | Common Stock | SSaleDisposed | −585 | $10.34 | −$6,048.9 | 40,414 | Direct | |
| Dec 1, 2023 | Common Stock | AGrant or awardAcquired | +7,233 | $0.00 | $0 | 47,647 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.